Contact maps published in Nature Biotechnology reveal direct contacts or protein interactions between more than 200 proteins. The International Union of Scientists, led by Dr. Pascal Falter-Braun, Director of the Helmholtz Institute for Network Biology (INET) in Munich at the University of Ludwig-Maximilan (LMU) in Munich and Professor of the School of Biology, includes teams from Canada, the United States, France, Spain, and Belgium.
Scientists at the Laboratory of Structural Bioinformatics and Network Biology, led by Dr. Patrick Aloy, a research professor at IRB ICREA in Barcelona, contributed to this work by analyzing the interaction network between viruses and human cells. They found that many viral proteins showed binding preferences for specific domains that are present in a variety of human proteins.
CONTENT
“Thanks to our expertise in structural biology. We were able to add a structural layer to the contact network, thus providing valuable insights,” said Dr. Carles Pons, an associate researcher at the laboratory.
“A better understanding of how viruses interact with our cells is key to pharmacologically preventing them. In fact, this consortium has successfully tested some compounds. Further research will now focus on assessing how genetic variability in the human host impacts these interactions,” Dr. Aloy explained.
In contrast to previous large-scale studies of protein-protein associations, direct protein contacts between viruses and hosts can now be precisely identified. Dr. Frederick Roth, a professor at the University of Toronto Donnelly Center and Sinai Health Center (Toronto, Canada), said: “To truly understand the mechanistic links between viruses and hosts, we need to know how these parts combine.”
By looking closely at this newly discovered set of direct protein interactions (or “contact groups”), the team discovered the connecting chains between viral proteins and human genes associated with infection. For example, they were able to track links between certain SARS-CoV-2 proteins and genetically encoded human proteins that have been associated with increased likelihood of severe COVID-19 in other studies. They also found links between viral proteins and genes, for example, involving metabolic disorders, such as obesity and diabetes. Dr. Falter-Braun said: “We already know that genetic differences in humans play an important role in the course and severity of COVID-19 infection. Thanks to the identification of molecular contact points, it is now possible to examine the underlying mechanisms.” Initial insights include the demonstration that important inflammatory signaling pathways are directly activated by the virus.
More
These contacts may help explain the exaggerated inflammatory response that plays an important role in severe cases of COVID-19. However, contact between proteins points not only to effects on the function of human cells and the human immune system. But also to effects on SARS-CoV-2 function, including the rate of viral replication. The interaction of the virus and human cells can be considered as a visit of the virus to a restaurant: the guest—the virus— was initially only in contact with the waiter. But subsequently, the waiter went to the kitchen and communicated the order to the cook. And the virus was replied again, which in turn affected the virus in this example. Infections and immune responses may differ based on proteins in human cells—i.e., waiters, cooks, kitchen assistants, etc.—that encounter viral proteins.
“Because of this interplay of protein-protein linkages, our system contact maps point to many potential drug targets,” Dr. Falter-Braun said. And its inhibitory effect significantly reduces viral propagation. “Many of the technologies and collaborations in this study were developed for other purposes and then quickly ‘turned’ to the COVID-19 pandemic, highlighting the value of basic research investment,” said lead author Dr. Dae-Kyum Kim. To do so, they first had to make some effort to use the latest technology, as mapping contacts sometimes seemed like solving a huge puzzle for international research teams. Scientists have systematically examined and shown interactions between about 30 viral proteins, each of which has been analyzed with about 17,500 human proteins, carefully screening 450,000 pairs of proteins.
No one can achieve such an achievement in such a short period of time if he uses his hand. “When we perform multiple tests on a single dish. We use artificial intelligence methods to initially assess whether interactions have occurred,” Dr. Falter-Braun said.
Source from Profacgen
Profacgen is a state-of-the-art protein service provider located in Long Island, NY, USA. We provide custom protein services in the biological sciences, enabling access to the latest tools, techniques. And expertise with competitive pricing and rapid turnaround time. We serve a broad spectrum of industrial and academic clients with a commitment to delivering high-quality data and customer services.
Protein expression and purification is where we started our business. We have unparalleled capacity in delivering custom proteins for both research needs and industrial scale.
And we provide a wide range of expression systems from procaryotic cells to eukaryotic cells to cell free and animal free systems, from transient expression to stable expression. We produce recombinant proteins according to our customer specifications or by developing customized protocols in house.
We also provide bioprocess scale-up services. Our fermentation laboratories are equipped with advanced bioreactors that enable us to produce protein at large scale. Our customers can choose to enter the protein expression pipeline at any stage.
We have acquired extensive experience and expert knowledge in protein interaction assays. Profacgen provide a comprehensive list of assays from initial screening (Y2H screening. Pull-down couple with MS analysis) to interaction validation (Co-IP, FRET etc.) to affinity and binding kinetics study (SPR analysis). We offer high-throughput screening services including enzyme substrate screening, GPCR screening, Transporter screening and Ion channel screening. We have developed specific assays for each of the above classes of molecules for accurate and high throughput study.
And We offer a large compound library and various cell models. Our screening service allows identification of specific substrates, activators, inhibitors agonists, antagonists or modulators.
We have also developed a series of protein engineering techniques including protein labeling by fluorescent dye, stable isotope, PEG, biotin etc. to meet the research requirements of our customers. We serve a broad spectrum of industrial and academic clients with a commitment to delivering high-quality data and customer services.
